| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/17/2008 | US20080014278 Metal-containing formulations and methods of use |
| 01/17/2008 | US20080014277 Reduced-odor thiol compositions |
| 01/17/2008 | US20080014276 Methods and devices for forming treatment agent carriers |
| 01/17/2008 | US20080014275 Pharmaceutical suspensions and related methods |
| 01/17/2008 | US20080014274 Enhanced stability phenylephrine liquid compositions |
| 01/17/2008 | US20080014273 Equine whole food supplements |
| 01/17/2008 | US20080014272 Compositions and Methods for Treatment of Chronic Pain Conditions |
| 01/17/2008 | US20080014271 Novel pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | US20080014270 Methods for improved lipid metabolism and basal metabolic rate with lactoferrin |
| 01/17/2008 | US20080014269 Oxacarbazepine film-coated tablets |
| 01/17/2008 | US20080014268 Orally disintegrating layered compositions |
| 01/17/2008 | US20080014267 Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 01/17/2008 | US20080014266 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 01/17/2008 | US20080014265 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 01/17/2008 | US20080014264 Novel pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | US20080014263 Amorphous eprosartan mesylate and process for the preparation thereof |
| 01/17/2008 | US20080014262 Rapidly disintegrating tablet containing polyvinyl alcohol |
| 01/17/2008 | US20080014261 Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 01/17/2008 | US20080014260 Solid dispersing vaccine composition for oral delivery |
| 01/17/2008 | US20080014259 Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same |
| 01/17/2008 | US20080014258 Administering (5-fluorouridine)-5'-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt; actinic keratosis |
| 01/17/2008 | US20080014257 Oral dosage forms |
| 01/17/2008 | US20080014256 having at least one enteric coating; oral bioavailability |
| 01/17/2008 | US20080014255 Liposome bonded with antibody and polyalkylene glycol |
| 01/17/2008 | US20080014254 Stable Crystal Modifications of Dotap Chloride |
| 01/17/2008 | US20080014253 Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof |
| 01/17/2008 | US20080014252 Topical compositions with long lasting effect |
| 01/17/2008 | US20080014250 Bifunctionalized polysaccharides |
| 01/17/2008 | US20080014248 Photosensitizer containing indole-3-alkylcarboxylic acid, and kit for photodynamic therapy containing the same |
| 01/17/2008 | US20080014247 Metal-containing formulations and methods of use |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014239 Multiple heparin molecules that are end-to-side and/or end-to-end connected glycosaminoglycan units attached to a globular core molecule, such as serum albumin, by a spacer such as N-succinylimidyl 3-(2-pyridyldithio)propionate; inhibition of collagen-induced platelet aggregation |
| 01/17/2008 | US20080014238 Implantable medical devices comprising semi-crystalline poly(easter-amide) |
| 01/17/2008 | US20080014237 Sustained release compositions, process for producing the same and use thereof |
| 01/17/2008 | US20080014231 Treatment articles capable of delivering intensive care and overall treatment simultaneously |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | US20080014224 Methods of Making Compositions Comprising Films |
| 01/17/2008 | US20080014223 Syrup Composition Comprising Dexibupropen as an Active Ingredient and Method for the Preparation Thereof |
| 01/17/2008 | US20080014174 Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte |
| 01/17/2008 | US20080014169 Compositions for Topical Enzymatic Debridement |
| 01/17/2008 | US20080014152 Intranasal delivery of clenbuterol across the cribriform plate and into the brain |
| 01/17/2008 | US20080014150 Compositions and method for treating precancerous virus infection and prevention of cancer |
| 01/17/2008 | US20080014144 Methods of Treatment with Drug Loaded Polymeric Materials |
| 01/17/2008 | US20080014008 Applicator and Method for Applying Lanolin to a Sore Nipple |
| 01/17/2008 | US20080011632 Absorbent Article Containing Fragrance |
| 01/17/2008 | US20080011613 Method of electrolytically depositing a pharmaceutical coating onto a conductive osteal implant |
| 01/17/2008 | US20080011293 Stable Xylometazoline and Oxymetazoline Solution |
| 01/17/2008 | US20080011240 Apparatus and methods for dispensing pet care substances |
| 01/17/2008 | DE4215677B4 Pharmazeutisches Mittel The pharmaceutical agent |
| 01/17/2008 | CA2659814A1 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 01/17/2008 | CA2659666A1 Improvements relating to pharmaceutical compositions |
| 01/17/2008 | CA2659382A1 Pharmaceutical suspensions comprising phenylephrine and method of preparation |
| 01/17/2008 | CA2659112A1 Multi-particulate formulation having tramadol in immediate and controlled release form |
| 01/17/2008 | CA2658241A1 Scfv antibodies which pass epithelial and/or endothelial layers |
| 01/17/2008 | CA2658170A1 Controlled-release formulations |
| 01/17/2008 | CA2658167A1 Devices and methods for delivering active agents to the osteomeatal complex |
| 01/17/2008 | CA2658081A1 Patch and patch preparation |
| 01/17/2008 | CA2657611A1 Enhanced stability phenylephrine liquid compositions |
| 01/17/2008 | CA2657592A1 Adhesive patch containing fentanyl or a pharmaceutically acceptable salt thereof |
| 01/17/2008 | CA2657586A1 Preparation of pharmaceutical formulations |
| 01/17/2008 | CA2657582A1 Preparation of pharmaceutical compositions |
| 01/17/2008 | CA2657581A1 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 01/17/2008 | CA2657548A1 Processes for preparing pharmaceutical compositions |
| 01/17/2008 | CA2657533A1 Drug delivery polymer with hydrochloride salt of clindamycin |
| 01/17/2008 | CA2657421A1 A method for the production of fentanyl-based anesthetics for their oral transmucosal administration in a candy-like dosage form |
| 01/17/2008 | CA2657379A1 Nanoparticulate sorafenib formulations |
| 01/17/2008 | CA2657332A1 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 01/17/2008 | CA2656788A1 Controlled release composition comprising polyurethane elastomers |
| 01/17/2008 | CA2656456A1 Combination of adapalene and benzoyl peroxide for treating acne lesions |
| 01/17/2008 | CA2656233A1 Improvements relating to pharmaceutical compositions |
| 01/17/2008 | CA2656229A1 Improvements relating to biocidal compositions |
| 01/17/2008 | CA2656223A1 Improvements relating to anti-parasitic compositions |
| 01/17/2008 | CA2656217A1 Improvements relating to nanodispersions |
| 01/17/2008 | CA2655838A1 Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production |
| 01/16/2008 | EP1879013A1 Method for the design of self-emulsifying drug formulations |
| 01/16/2008 | EP1878766A1 Electrostatic bonding type polymer vesicle |
| 01/16/2008 | EP1878754A1 Preparation and application of heparin silver |
| 01/16/2008 | EP1878742A2 HIV peptides, antigens, vaccine compositions, immunoassay and a method of detecting antibodies induced by HIV |
| 01/16/2008 | EP1878664A1 Process for producing metered dose inhaler formulations |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1878445A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients |
| 01/16/2008 | EP1878437A2 Pharmacuetical formulations for sustained drug delivery |
| 01/16/2008 | EP1878435A1 Composition for inducing sleep containing vegetable essential oil component as the active component, transdermal absorption type sleep inducing agent containing the composition and method of producing the same |
| 01/16/2008 | EP1878431A1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues |
| 01/16/2008 | EP1878429A1 Trenadermal absorption preparation |
| 01/16/2008 | EP1878426A1 Granular preparation containing biguanide compound |
| 01/16/2008 | EP1878425A1 Transdermal absorption accelerator |
| 01/16/2008 | EP1878424A2 Novel vaccine |
| 01/16/2008 | EP1878044A2 Xerogel films for the controlled release of pharmaceutically active molecules |
| 01/16/2008 | EP1877096A1 Non-lithotripsic kidney-stone therapy |
| 01/16/2008 | EP1877077A2 An implantable interferon-containing device |
| 01/16/2008 | EP1877059A2 Micronized tanaproget and compostions containing same |
| 01/16/2008 | EP1877058A2 Use of phycotoxins in veterinary applications |
| 01/16/2008 | EP1877042A2 Bioenhanced compositions |
| 01/16/2008 | EP1877041A2 Therapeutic compositions |
| 01/16/2008 | EP1877040A1 Extended release formulations |
| 01/16/2008 | EP1877039A1 Polyethylene glycol colonic purgative composition |
| 01/16/2008 | EP1877038A2 Cell-surface decoration with active agents |
| 01/16/2008 | EP1877037A2 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 01/16/2008 | EP1877035A2 Pharmaceutical composition and dosage form fast-disintegrating in the mouth , and process to prepare it |